Skip to content

Acupuncture Treatment for Lower Motor Neuron-Related Neurogenic Bladder: A Randomized Controlled Trial

Acupuncture Treatment for Lower Motor Neuron-Related Neurogenic Bladder: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001376
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenic bladder

Interventions

Experimental group:Acupuncture
Control group:Sham acupuncture

Sponsors

Cangzhou Hospital of Integrated Traditional Chinese and Western of Hebei Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with confirmed lower motor neuron damage resulting from spinal cord injury, pelvic disease, or a history of surgery, meeting the aforementioned diagnostic criteria of both traditional Chinese and Western medicine. (2) Residual urine volume >100 mL and increased bladder capacity. (3) Age 18–75 years. (4) Disease duration of 1–6 months. (5) Stable condition, alert and oriented, and able to cooperate with treatment and assessment. (6) No prior acupuncture-related treatment prior to enrollment. (7) Voluntary participation and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe heart, brain, or lung diseases, or those with severe mental disorders. (2) Patients with skin lesions at the treatment site, such as bleeding tendencies or pressure ulcers. (3) Patients with congenital urethral valves or urethral strictures, or those with non-neurogenic neurogenic bladder. (4) Patients with urinary tract tumors, severe urinary tract infections, or kidney disease. (5) Patients with a history of cystostomy or anterior urethral sphincterotomy, urinary diversion surgery, or those with a urethral stent or prosthesis. (6) Patients with urodynamic studies indicating detrusor overactivity or significant organic obstruction at the urethral outlet. (7) Pregnant or lactating women. (8) Patients with metallic foreign bodies implanted in the lower lumbar or sacrococcygeal regions, etc. (9) Patients who have undergone surgical procedures such as sacral nerve or sacral cord stimulation device implantation. (10) Patients currently participating in other clinical trials that may affect the evaluation of the results of this study.

Design outcomes

Primary

MeasureTime frame
Neurogenic Bladder Symptom Score;

Secondary

MeasureTime frame
Urodynamics;Color Doppler Ultrasound of the Urinary Tract;Urination Diary;Neurogenic Bladder Symptom Score-Short Form;Traditional Chinese Medicine Syndrome Points;

Countries

China

Contacts

Public ContactShiqiang Zhang

Cangzhou Hospital of Integrated Traditional Chinese and Western of Hebei Province

zhangshiqiang0811@163.com15075760811

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026